Updates are available Correction dated 2023-04-25
Click to view Correction: https://doi.org/10.1186/s12954-023-00784-z
-
Authors
Volpe, Isabelle
Brien, Rita
Grigg, Jasmin
Tzanetis, Stephanie
Crawford, Sione
Lyons, Tom
Lee, Nicole
McKinnon, Ginny
Hughes, Caitlin
Eade, Alan
Barratt, Monica J.
-
Funding
Funding for this research was provided by:
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
National Centre for Clinical Research on Emerging Drugs (NCR3SF03)
- License Information
-
More Information
Article History
Received: 23 March 2022
Accepted: 22 October 2022
First Online: 9 January 2023
Change Date: 25 April 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12954-023-00784-z
Declarations
:
: Ethical approval for the project was granted by the RMIT College Human Ethics Advisory Network on 18 December 2019 (22591-11/19). Participants were provided explanatory statements about research objectives, process, and intention to publish results prior to data collection. Informed consent was recorded digitally via an approved electronic Participant Information Sheet/Consent Form, which included explicit consent for researchers to report deidentified data and findings.
: IV, RB, GM, and MJB are volunteers for The Loop Australia (TLA), a health promotion charity working towards delivering drug checking services in Australia that repackages and shares drug alert information with its networks. NL also sits on the board of TLA.
